Bill > HF743

This bill prohibits health plans that provide diabetes treatment coverage from using step therapy protocols (a cost-control method requiring patients to try less expensive medications before covering more costly treatments) for prescription insulin drugs. The bill defines diabetes as the three types recognized by the Centers for Disease Control and Prevention and provides specific definitions for "prescription insulin drug" and "step therapy protocol." By mandating this prohibition, the bill ensures that patients with diabetes will have more direct access to insulin medications without having to first try alternative or less expensive options that may not be as effective for their specific medical needs. The provisions will take effect on January 1, 2027, and will apply to health plans offered, issued, or renewed on or after that date. The bill amends existing Minnesota statutes related to health insurance and Medicaid drug formulary procedures, specifically updating section 256B.0625 to reflect this new requirement and ensure compliance with the step therapy prohibition for insulin drugs.

Business and Industry

https://www.revisor.mn.gov/bills/bill.php?b=House&f=HF0743&ssn=0&y=2025